TFEB and renal cell carcinoma: Given the close correlation between the above partial enrichment pathway and amplified mutations of the TFEB gene, which was consistent with our previous CNV results suggesting the presence of TFEB amplification, the rationale supporting the diagnosis of TFEB-amplified renal cell carcinoma was more robust.